Aortic Stenosis-Associated Cardiac Damage: A Comparison Between Patients Treated with Surgery and Transcatheter

Ricardo Román1, Fabián Islas2, Patrick O'Neill-González1

  • 1Instituto Cardiovascular, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain.

PubMed

Insights

Patients undergoing transcatheter aortic valve replacement (TAVR) for severe aortic stenosis (AS) show more extensive cardiac damage than surgical aortic valve replacement (SAVR) patients. Earlier intervention before advanced damage may improve outcomes.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Interventional Cardiology

Background:

  • Severe aortic stenosis (AS) can lead to extra-valvular cardiac damage.
  • This damage is linked to patient outcomes after aortic valve interventions.

Purpose of the Study:

  • To compare AS-related cardiac damage between surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) patients.
  • To analyze the impact of cardiac damage stages on 1-year mortality post-intervention.

Main Methods:

  • Retrospective analysis of 874 patients with severe AS undergoing SAVR or TAVR (2017-2022).
  • Comparison of pre-intervention clinical and echocardiographic parameters.
  • Classification of patients using Généreux and Gutiérrez-Ortiz staging systems for cardiac damage.
  • Assessment of 1-year all-cause mortality based on damage stages.

Main Results:

  • TAVR patients were older, more frequently female, and had higher surgical risk than SAVR patients.
  • TAVR patients exhibited significantly more advanced cardiac damage (right-sided) compared to SAVR patients, per both staging systems.
  • Higher mortality was observed in patients with right-sided damage, irrespective of intervention type or staging system.

Conclusions:

  • Contemporary severe symptomatic AS patients treated with TAVR present with more extensive cardiac damage than SAVR patients.
  • This highlights the importance of intervention timing, particularly for TAVR candidates.
  • Earlier intervention prior to advanced cardiac damage may lead to improved patient outcomes.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
413
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
530
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
776